PMC:7358770 / 1260-1434
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 44 | 28-36 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 45 | 110-118 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T6 | 28-36 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 110-118 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 72-73 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T22 | 2-15 | Chemical | denotes | nanoparticles | http://purl.obolibrary.org/obo/CHEBI_50803 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 48-151 | Sentence | denotes | This review may provide a new approach for the development of COVID-19 therapeutic agents and vaccines. |
| T11 | 153-163 | Sentence | denotes | Highlights |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T32 | 28-36 | SP_7 | denotes | COVID-19 |
| T33 | 110-118 | SP_7 | denotes | COVID-19 |
| T2888 | 28-36 | SP_7 | denotes | COVID-19 |
| T81998 | 110-118 | SP_7 | denotes | COVID-19 |
| T9312 | 40-44 | SP_10 | denotes | atme |
| T76017 | 54-61 | GO:1990524 | denotes | eview m |
| T40956 | 71-75 | G_3;PG_10;PR:000003622 | denotes | a n |
| T79562 | 120-123 | PR:000005225 | denotes | her |
MyTest
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 44 | 28-36 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 45 | 110-118 | Disease | denotes | COVID-19 | MESH:C000657245 |